Defence Announces Closing of Securities for Debenture Financing #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Financing #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in addition to novel immune-oncology vaccines, announces that it has closed its offering of unsecured convertible debentures (the "New Debentures") for aggregate gross proceeds of...
http://dlvr.it/TGLSD5
http://dlvr.it/TGLSD5
Comments
Post a Comment